ReviewFrontiers in immunology2025

MAPPs assays for non-clinical immunogenicity risk assessment: best practices recommended by the European immunogenicity platform.

A C Karle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.